AstraZeneca to invest $50 bln in US as pharma tariffs loom | REUTERS

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the US by 2030, it said, the latest big investment by a pharmaceutical company reacting to President Trump's tariff policy. #News #AstraZeneca #US #Trump #tariff #Reuters #Newsfeed Read the story here: https://reut.rs/3IUFOi2 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en